Clinical Trial Update: L9LS MAb in Malian Infants [Phase 1]

View source ↗

Summary

Phase 1 trial update for the L9LS monoclonal antibody in Malian infants; the study investigating malaria prevention is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• L9LS MAb (L9LS monoclonal antibody)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 1 | Status: ACTIVE_NOT_RECRUITING